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HEART FAILURE
Reversible Restrictive Left Ventricular Diastolic Filling With
Optimized Oral Therapy Predicts a More Favorable Prognosis in
Patients With Chronic Heart Failure
PIER L. TEMPORELLI, MD, UGO CORRA`, MD, ALESSANDRO IMPARATO, MD,
ENZO BOSIMINI, MD, FRANCESCO SCAPELLATO, MD, PANTALEO GIANNUZZI, MD
Veruno, Italy
Objectives. We sought to assess whether in clinically stable
patients with chronic heart failure (CHF) the prolongation (i.e.,
increase) of an initially short (<2125 ms) Doppler transmitral
deceleration time (DT) of early filling obtained with long-term
optimal oral therapy predicts a more favorable prognosis.
Background. It has been recently demonstrated that transmi-
tral early DT is a powerful independent predictor of poor prog-
nosis in patients with left ventricular dysfunction. However, DT
may change over time according to loading conditions and medi-
cal treatment.
Method. One hundred forty-four patients with CHF and a short
DT (<2125 ms) underwent repeat Doppler echocardiographic
study 6 months after the initial examination, while clinically
stable with optimal oral therapy, and were then followed up for a
mean period of 26 6 7 months.
Results. After 6 months, DT had not changed in 80 patients
(group 1), whereas it was significantly prolonged (>125 ms) in the
remaining 64 patients (group 2). Baseline Doppler echocardio-
graphic features were similar in the two groups. No changes were
found after 6 months in group 1, whereas group 2 showed a slight
but significant (p < 0.01) reduction in end-systolic volume, an
improvement in left ventricular ejection fraction (p < 0.01) and a
decrease (p < 0.01) in the degree of tricuspid regurgitation.
During follow-up, 37% of patients in group 1 experienced cardiac
death versus 11% in group 2 (p < 0.0005). By Cox model analysis,
prolongation of a short DT emerged as the single best predictor of
survival (chi-square 15.70).
Conclusions. The prolongation of an initially short DT obtained
with long-term optimal oral therapy predicts a more favorable
outcome in clinically stable patients with CHF.
(J Am Coll Cardiol 1998;31:1591–7)
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It is now well recognized that Doppler echocardiography of
mitral flow is a useful tool for assessing left ventricular (LV)
filling abnormalities in various cardiac diseases (1–7). In
patients with LV dysfunction the mitral flow velocity pattern
has been shown (1,5–15) to correlate with symptoms, central
hemodynamic variables and prognosis. In particular, the so-
called restrictive pattern, characterized by a shortened isovolu-
metric relaxation time and deceleration time (DT) of early
filling, together with an increased ratio of peak flow velocity in
early to late diastole, is associated with elevated LV filling
pressures, more severe functional status and poor exercise
capacity. In recent years, it has been demonstrated (13) that
Doppler-derived mitral DT of early filling, as an index of
restrictive LV diastolic filling irrespective of the filling pattern,
provides a simple and noninvasive method of estimating and
monitoring pulmonary capillary wedge pressure in patients
with severe LV systolic dysfunction. More recently still, a short
(#125 ms) mitral DT has also been proved to be a powerful
independent predictor of poor prognosis in both symptomatic
and asymptomatic patients with LV systolic dysfunction (16).
However, in view of the dynamic nature of LV filling, DT
together with the restrictive pattern may change over time
after loading manipulations as a function of variations in LV
filling pressures. In other words, an optimal therapeutic regi-
men may reverse a restrictive pattern and normalize a short
DT; but to date, the prognostic value of these changes has been
only poorly investigated.
Accordingly, the aim of the present study was to assess
whether an increase in an initially short (#125 ms) early DT,
as an expression of reversible restrictive physiology, obtained
with long-term optimal oral therapy could predict a more
favorable prognosis in patients with chronic heart failure
(CHF).
Methods
Subjects. Patients with LV systolic dysfunction (echocar-
diographic LV ejection fraction #35%) and CHF due to either
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ischemic or nonischemic dilated cardiomyopathy, in clinically
stable condition for at least 3 weeks with oral therapy and with
a short DT (#125 ms) of early filling on Doppler echocardi-
ography irrespective of the ratio of early (E) to late (A)
diastolic filling (E/A ratio) were eligible for the study. Patients
were ineligible if they were .75 years old or if they had any of
the following: echocardiographic images and transmitral Dopp-
ler tracings of inadequate quality for analysis, atrial fibrillation,
severe valvular stenosis, unstable angina pectoris or myocardial
ischemia requiring revascularization, myocardial infarction
during the previous 3 months, severe pulmonary diseases,
coronary artery bypass graft procedures during the previous 6
months, cancer or other systemic disease affecting survival.
From December 1992 through December 1995, 265 patients
were consecutively evaluated in our heart failure unit for
possible enrollment. Of these 265 patients, 185 met the entry
criteria for the study. All patients gave their written informed
consent to participate in this prospective study, which had been
approved by the science and ethics committee of our institution.
Study protocol. The study consisted of two parts: clinical
evaluation and Doppler echocardiography at rest, both at entry
and 6 months later, and follow-up. Patients enrolled under-
went clinical examination and a complete Doppler echocardio-
graphic study at rest; a second evaluation was scheduled for 6
months later, provided that patients were clinically stable. In
the interim, patients were to receive an optimal oral therapeu-
tic regimen. Angiotensin-converting enzyme inhibitors and
beta-adrenergic blocking agents were gradually increased to
the target or the maximal tolerated dosage. The target dosage
for enalapril and captopril were 10 mg twice a day and 50 mg
three times/day, respectively. The target dosage for metoprolol
and carvedilol were 50 mg twice a day and 25 mg twice a day,
respectively. Diuretic drugs were administered in flexible dos-
ages on the basis of body weight and daily diuresis. Digitalis
was titrated to reach a serum concentration between 0.8 and 2
ng/ml. Of the 185 patients initially enrolled, 41 experienced
severe adverse events (hospital admission for heart failure or
death) before the second evaluation; the remaining 144 pa-
tients, clinically stable in the absence of cardiac events, under-
went the repeat Doppler echocardiographic study after 6
months and were then followed up for a mean (6SD) period of
26 6 7 months. During follow-up, the therapeutic regimen was
not influenced by Doppler DT results at the second evaluation.
Stable clinical condition was defined as stable body weight and
fluid balance and the absence of signs of pulmonary or
peripheral congestion.
The functional status of patients at the time of the Doppler
echocardiographic study was determined according to New
York Heart Association class. Asymptomatic patients were
assigned to functional class I, mildly symptomatic patients to
class II, those moderately symptomatic to class III and those
very symptomatic at minimal activity or rest to class IV.
Echocardiography. A complete two-dimensional echocar-
diographic and Doppler ultrasound examination was per-
formed in all patients at the entry evaluation and after 6
months by means of a Hewlett-Packard ultrasound system
(model 77729-A or 77622-A) with 2.5- and 3.5-MHz probes.
Images were stored on a Panasonic videotape recorder (AG-
7330E) for further analysis.
LV volumes were calculated from orthogonal apical views
using the area–length method. LV ejection fraction was de-
rived from the standard equation. Maximal atrial area and
right ventricular end-diastolic diameter 1 cm below the tricus-
pid annulus were also measured from the apical four-chamber
view. Mitral regurgitation was diagnosed and semiquantita-
tively graded by color-flow Doppler as none, mild, moderate or
severe according to previously reported criteria (17). Mitral
flow velocity was assessed by pulsed-wave Doppler echocardi-
ography in the apical four-chamber view with the sample
volume positioned between the tip of the mitral leaflets, where
maximal flow velocity was recorded (1,5). Care was taken to
obtain the smallest possible angle between the presumed
direction of the diastolic blood flow and the orientation of the
ultrasound beam. Traces of five to eight consecutive cycles
were analyzed using a microcomputer-based digitizing system,
and the following variables were measured: maximal early
diastolic velocity (peak E), maximal late diastolic velocity
(peak A), their ratio (peak E/A) and the DT of early filling. DT
was measured as previously described (1,13). Cardiac cycles
with nonlinear deceleration slopes and fusion of early and late
mitral flow velocity were excluded from the analysis.
Follow-up data. After the second examination, patients
were seen in our outpatient clinic at regular intervals (on
average every 6 months). Patients who did not attend the
scheduled appointments were followed up by chart review or
contact with the treating physician, telephone interview with
the patient conducted by trained personnel or review of the
patient’s hospital record. Outcome events were cardiovascular
mortality, heart transplantation while in critical condition
(status 1), hospital admission for worsening heart failure and
cumulative events (death, transplantation or hospital admis-
sion for heart failure). Only one event was considered in each
patient, and any event occurring after the initial event was not
considered.
Statistical analysis. All descriptive data are given as mean
value 6 SD. Differences between patients were compared by
unpaired t testing and frequency of variables and events by the
chi-square test with the Yates correction. Differences between
groups and changes over time within each group, as well as any
interaction (different trends between groups), were assessed by
multivariate repeated measures analysis of variance. Those
variables that showed a significant association with the out-
come were included in the multivariate Cox model in stepwise
Abbreviations and Acronyms
CHF 5 chronic heart failure
DT 5 deceleration time
E/A ratio 5 ratio of early to late diastolic filling
LV 5 left ventricular
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fashion. Survival was estimated by the product-limit Kaplan-
Meier method. Differences between survival curves were
tested with the log-rank chi-square statistic. A p value ,0.05
was considered statistically significant.
Results
Patients. The study included 144 patients (118 men, 26
women; mean age 57 6 9 years) with CHF and a short
(#125 ms) early DT. All patients had had at least one
unequivocal episode of clinical heart failure. The etiology of
heart failure was coronary artery disease in 75% of patients
and idiopathic dilated cardiomyopathy in the remaining 25%.
Mean left ventricular ejection fraction was 22 6 6%. Forty-
nine patients (44%) were in functional class III or IV; the
other 95 (66%) were in functional class II.
Mitral flow velocity pattern changes. At the second evalu-
ation (6 months after initial examination), the DT of early
filling had not changed in 80 patients (group 1, persistent short
DT); the remaining 64 patients showed a significant prolonga-
tion (.125 ms) of DT (group 2, prolonged DT). Baseline
clinical characteristics of the two study groups are shown in
Table 1. More patients in group 1 were in functional class III
or IV (p 5 0.03) and had been given digitalis (82% vs. 66%,
p 5 0.02); all other clinical variables were well comparable
between the two groups. Of significance, when treatment was
optimized after the first evaluation, medical therapy between
the two studies was similar in both groups (Table 2).
Table 3 shows Doppler echocardiographic variables at
baseline and after 6 months in the two groups. At baseline, all
echocardiographic and transmitral Doppler variables consid-
ered were similar in the two groups. After 6 months, no
significant changes could be seen in patients with persistent
short (#125 ms) DT of early filling (group 1), whereas DT had
increased from 107 6 14 to 165 6 33 ms (p , 0.001) in those
with a significant prolongation of DT (group 2); moreover, in
group 2 the E/A ratio was lower (p , 0.001), end-systolic
volumes had slightly decreased (p , 0.01), LV ejection fraction
had improved (p , 0.001), and the number of patients with
moderate to severe tricuspid regurgitation had also decreased
(p , 0.001).
Outcome. Follow-up data were available for 141 (98%) of
the 144 patients enrolled. During a mean follow-up period of
26 6 7 months, 37 patients (26%) died of cardiovascular
causes, 7 (5%) underwent transplantation while in critical
condition, and 49 (34%) were admitted to the hospital for
worsening heart failure. Overall, there were 75 hard events
(52%). No patient died of noncardiac causes. Of the 37
patients with cardiac death, 21 died of progressive heart failure
and 16 of sudden death. The two patients who underwent
elective transplantation while their clinical condition was sta-
ble were excluded from the analysis at the date of the
transplantation.
There were 30 cardiac deaths (37%) in group 1 (persistently
short DT) as opposed to 7 (11%) in group 2 (prolonged DT)
(p , 0.0005). Fewer patients (7 [11%]) were admitted to the
hospital for worsening heart failure in group 2 than in group 1
(42 [54%]) (p , 0.0000). Moreover, fewer patients underwent
urgent transplantation while in critical condition in group 2 (1
[1.5%]) than in group 1 (6 [7.5%]), although the difference was
not statistically significant (p , 0.2). Overall, cumulative
cardiovascular events (defined as cardiac death, urgent trans-
plantation and hospital admission for worsening heart failure)
were significantly lower in group 2 than in group 1 (24% vs.
77%, p , 0.0001).
On univariate analysis, several echocardiographic and mi-
tral Doppler variables, including changes between baseline and
6-month evaluation, together with functional status were found
to be predictive of fatal outcome (Table 4). Of note, no specific
medication at baseline or during the 6-month period of
optimized therapy emerged as significantly associated with
prognosis. When multivariate analysis in a forward stepwise
regression procedure was performed (including in the model
baseline echocardiographic and mitral Doppler variables with
Table 1. Baseline Clinical Characteristics of Study Patients
According to Study Group
Group 1
(persistent
short DT)
(n 5 80)
Group 2
(prolonged DT)
(n 5 64)
Age (yr) 57 6 9 57 6 9
Men/women 60 (75%)/20 (25%) 44 (69%)/20 (31%)
Cause of HF
Ischemic 76% 75%
Nonischemic idiopathic 24% 25%
Duration of HF (days) 835 6 154 837 6 179
NYHA functional class
III or IV
35 (44%)* 14 (22%)
Therapy
Digitalis 66 (82%)* 42 (66%)
Diuretic drugs 66 (82%) 49 (77%)
ACE inhibitors 56 (70%) 45 (70%)
Nitrates 53 (66%) 45 (70%)
Beta-blockers 6 (8%) 11 (17%)
*p , 0.05 between groups. Data presented are mean value 6 SD or number
(%) of patients. ACE 5 angiotensin-converting enzyme; DT 5 deceleration time
of early filling; HF 5 heart failure; NYHA 5 New York Heart Association.
Table 2. Medications During the 6 Months Between Baseline and
Late Evaluation in the Two Study Groups
Group 1
(persistent
short DT)
(n 5 80)
Group 2
(prolonged DT)
(n 5 64)
Digitalis 66 (82%) 46 (72%)
Diuretic drugs 72 (90%) 55 (86%)
ACE inhibitors 63 (78%) 56 (87%)
Nitrates 60 (75%) 49 (76%)
Beta-blockers 21 (26%) 16 (25%)
Data presented are number (%) of patients. Differences between groups are
not statistically significant. Abbreviations as in Table 1.
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their changes at 6 months and the use of medications both at
entry and between the two evaluations), only prolongation of
an initially short DT, LV end-systolic volume and tricuspid
regurgitation at entry and changes in LV ejection fraction
between baseline and late evaluation emerged as independent
predictors of survival (Table 5). Prolongation of a short DT
proved to be the single best predictor (chi-square 15.7%).
Furthermore, when survival without hospital admission for
CHF and survival without any cardiovascular events (hospital
admission for heart failure, urgent transplantation or death)
were analyzed, prolongation of a short DT still emerged as the
most powerful independent predictor (Table 5). Survival free
of death, survival free of hospital admission for heart failure
and event-free survival according to the evolution of DT are
reported in Figure 1. The 4-year cumulative mortality rate was
48% in patients with a persistent short DT and 14% in those
with a prolonged DT (p , 0.0005). Moreover, the cumulative
4-year incidence rate of all hard events was 86% in patients
with a persistent short DT and 36% in those with a prolonged
DT (p , 0.0001).
Discussion
The present study demonstrates that in clinically stable
patients with CHF, significant prolongation of an initially short
(#125 ms) DT of early filling may be obtained after 6 months
of optimized oral therapy and clearly identifies patients with
more favorable outcome.
Conversely, a higher risk for fatal outcome can be predicted
by a group of noninvasive variables, including a persistently
short DT, the presence of moderate to severe tricuspid regur-
gitation, lack of change in LV ejection fraction over time and
LV end-systolic volume at entry. All these variables are
independent prognostic indicators, persistent short DT being
the single best predictor of cardiac mortality. Over a 4-year
follow-up period, cardiac death occurred in 48% of patients
with DT persistently #125 ms after 6 months of optimized
medical therapy but in only 14% of patients showing a
significant prolongation of a short DT after such therapy (Fig.
1A). Furthermore, a persistently short DT proved the most
important predictor of hospital admission for worsening heart
failure and cumulative cardiac events (death, urgent transplan-
tation and hospital admission for heart failure).
Comparison with previous studies. Several studies (1,2,4,
13,14,18–20) have shown that a restrictive transmitral flow
pattern is strongly related to LV filling pressure and the
severity of clinical symptoms of various cardiovascular disor-
ders. More recent studies (8–12,15) have also clearly demon-
strated the prognostic value of the restrictive pattern and,
more recently still, of a short DT (#125 ms) of early filling (16)
in patients with LV dysfunction. However, in those studies
mitral flow pattern was assessed only once, which could be a
limitation because we know that the transmitral filling pattern
may change over time according to loading conditions and
medical treatment. To date, few studies (and featuring only
small groups of patients with a short follow-up period) have
investigated the prognostic power of a favorable evolution of
the restrictive pattern (21–24), namely, its normalization by
Table 3. Echocardiographic and Mitral Doppler Features of Study Cohort According to Study Group
at Baseline and After 6 Months
Group 1
(persistent short DT)
(n 5 80)
Group 2
(prolonged DT)
(n 5 64)
Baseline* 6 mo Baseline* 6 mo
Echo data
HR (beats/min) 76 6 14 74 6 16 77 6 13 74 6 17
LVEF (%) 21 6 7 21 6 7 23 6 6 26 6 7†‡
LVEDVI (ml/m2) 133 6 35 135 6 22 125 6 43 120 6 43‡
LVESVI (ml/m2) 106 6 34 107 6 34 100 6 40 90 6 39†‡
LA area (cm2) 23 6 6 24 6 6 23 6 6 22 6 5‡
RA area (cm2) 16 6 5 17 6 5 16 6 5 15 6 4
RVEDD (mm) 30 6 5.7 31 6 5.5 29 6 5.6 29 6 5.5
Mod–severe MR 39 (49%) 42 (52%) 36 (56%) 32 (50%)
Mod–severe TR 21 (26%) 24 (30%) 18 (28%) 6 (9%)†‡
Mitral Doppler data
Peak E velocity (cm/s) 98 6 21 98 6 21 94 6 19 74 6 22†‡
Peak A velocity (cm/s) 41 6 23 46 6 23 45 6 23 71 6 23†‡
E/A ratio 2.5 6 1.1 2.3 6 1.5 2.3 6 1.3 1.2 6 0.8†‡
DT (ms) 102 6 15 101 6 16 107 6 14 165 6 33‡
*p 5 NS for between-group baseline differences. †p , 0.01 versus baseline in group 2. ‡p , 0.001 interaction
(different trends between groups). Data presented are mean value 6 SD or number (%) of patients. A 5 atrial
contraction; DT 5 deceleration time of early filling; E 5 early diastole; Echo 5 echocardiographic; HR 5 heart rate;
LA 5 left atrial; LVEDVI 5 left ventricular end-diastolic volume index; LVEF 5 ejection fraction; LVESVI 5 left
ventricular end-systolic volume index; Mod 5 moderate; MR 5 mitral regurgitation; RA 5 right atrial; RVEDD 5 right
ventricular end-diastolic diameter; TR 5 tricuspid regurgitation.
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means of a reduction of the E/A ratio or prolongation of a
short early DT, or both.
Of these latter studies, Klein et al. (21) and Werner et al.
(22), investigating patients with cardiac amyloidosis and with
dilated cardiomyopathy, indicated that changes in transmitral
flow pattern occur during serial Doppler echocardiographic
evaluations and that they are closely related to changes in
clinical condition and course of the disease. Still more recent
data by Traversi et al. (23) and Pozzoli et al. (24), in a group of
patients with CHF closely comparable to our study cohort,
showed that changes in transmitral flow pattern after loading
manipulations or long-term optimized therapy are correlated
with changes in central hemodynamic variables and functional
capacity and provide relevant independent prognostic informa-
tion. However, in those studies focusing on the evolution of the
LV diastolic filling, the restrictive pattern was defined by an
E/A ratio $2 or by the combination of an E/A ratio between 1
and 2 and a DT #140 ms.
In the present study—on the basis of the recent demon-
stration of the independent predictive power of a short
(#125 ms) Doppler transmitral early DT in patients with CHF
irrespective of the filling pattern as defined by the E/A ratio
(16)—we enrolled patients purely on the basis of a short DT
(#125 ms) as an index of restrictive LV diastolic filling, and to
our knowledge, investigated for the first time the prognostic
contribution of changes over time of this transmitral Doppler
variable. In agreement with our previous experience (16), we
confirmed here that in patients with CHF, a short early DT
(#125 ms) is associated with a very high event rate: 41 of the
185 patients initially enrolled experienced an adverse cardiac
event (death or hospital admission for worsening heart failure)
before the second evaluation at 6 months and were excluded
from the study; in the remaining 144 patients who completed
the study protocol, with a second Doppler echocardiographic
evaluation after 6 months of clinical stability under optimized
therapy, there were a further 44 hard events (31%) (death or
urgent transplantation while in critical condition) and 49
hospital admissions for worsening CHF (35%). Nevertheless,
in this cohort we also found that up to 44% of patients showed
a significant prolongation of their initially short early DT (i.e.,
reversible restrictive LV diastolic filling) after 6 months of
clinical stability with optimal oral therapy (group 2), and these
patients had a substantially better outcome. Thus, we believe
that our study is the first to clearly demonstrate that, irrespec-
tive of E/A ratio changes, prolongation of an initially short DT,
which may occur in a sizeable number of patients with CHF
with long-term optimal therapy, predicts a more favorable
prognosis.
Of note, although at univariate analysis an E/A ratio .2
and its variation over time were significantly associated with a
worse outcome, at multivariate analysis these variables did not
prove to be independent prognostic indicators. On the con-
trary, a persistently short early DT (#125 ms) (which was
associated with an E/A ratio ,2 in 26% of patients) was found
to be the single most powerful indicator of poor prognosis,
whereas a prolongation of an initially short DT, which was
usually accompanied by a significant reduction in E/A ratio,
was associated with a 66% risk reduction of cardiac mortality.
Mechanisms. How can this different evolution in transmi-
tral flow be explained in patients with comparable clinical and
Doppler echocardiographic features, and why are these
changes related to progression of heart failure and prognosis?
In fact, more patients with a persistent short DT were in
NYHA class III to IV at entry and were receiving digitalis,
even though during the 6-month period of optimized therapy
between the two Doppler echocardiographic studies, medica-
tions became equally distributed between the two groups, and
no specific therapeutic intervention was found predictive of
subsequent conversion to a nonrestrictive pattern. Moreover,
Table 4. Univariate Analysis: Predictors of Fatal Outcome
Variable
Global
Chi-Square
p
Value
Clinical data at entry
Age 2.2 0.1
Cause of HF
Ischemic 0.27 0.6
Nonischemic idiopatic 0.26 0.6
NYHA class at entry 11.23 0.0008
Duration of HF 1.70 0.056
Echo data—early study
HR 2.3 0.12
LVEF 7.20 0.007
LVEDVI 7.19 0.0042
LVESVI 8.88 0.0029
LA area 4.27 0.038
RA area 2.30 0.12
RVEDD 1.22 0.26
MR grade 3.32 0.068
TR grade 5.82 0.01
Mitral Doppler data—early study
DT 0.14 0.7
Peak E 0.40 0.5
Peak A 0.11 0.7
E/A ratio .2 4.26 0.035
Therapy at entry
Digitalis 2.10 0.14
Diuretic drugs 4.16 0.047
ACE inhibitors 0.001 0.9
Nitrates 0.02 0.89
Beta-blockers 1.43 0.2
Optimized therapy
Digitalis 1.8 0.16
Diuretic drugs 2.4 0.1
ACE inhibitors 0.001 0.9
Nitrates 0.8 0.4
Beta-blockers 1.1 0.1
Baseline vs. 6-mo evaluation
DHR 1.5 0.3
DLVEF 11.81 0.0006
DLVEDVI 4.33 0.037
DLVESVI 7.95 0.0048
DE/A ratio 7.80 0.005
Persistent short DT (#125 ms) 16.62 0.0000
D 5 change in; other abbreviations as in Tables 1 to 3.
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at multivariate analysis, medications both at baseline and
during the 6 months between baseline and late evaluation were
not independently related to survival, and a persistently short
DT proved the best independent predictor of fatal outcome
over other variables, including functional class.
Although the duration of heart failure was similar in the
two groups, patients who showed a significant prolongation of
an initially short DT at entry had slightly less enlarged,
although not significantly, LV volumes and a slightly higher LV
ejection fraction. Thus, it could be hypothesized that patients
with a reversible short DT had a lesser extent of fibrosis and
probably some residual contractile reserve, as confirmed by the
significant decrease in end-systolic volume and the small but
significant improvement in LV ejection fraction at 6 months. A
favorable evolution of the restrictive LV filling as a function of
reduction in elevated filling pressures with optimized long-
term therapy may have facilitated or at least paralleled this
modest functional improvement and may also have exerted a
positive influence on the progression of heart failure and
prognosis. On the contrary, patients with persistent restrictive
LV diastolic filling, as documented by a persistent short DT
and, consequently, elevated filling pressures, could have had
more extensive fibrosis refractory even to optimized long-term
unloading therapy, although this possibility could not have
been predicted by traditional echocardiographic markers of
LV dimension and function.
Therefore, in light of the well known correlations between
mitral Doppler variables (1–4,18–20), particularly DT of early
filling (13), and central hemodynamic variables (i.e., the
shorter the DT the higher the pulmonary wedge pressure) in
patients with LV dysfunction and CHF, it is reasonable to
speculate that prolongation of an initially short DT (namely,
the reduction in pulmonary wedge pressure) may result in a
beneficial effect on the long-term outcome. The results of the
present study strongly support this hypothesis.
Study limitations. We studied patients with CHF with
sinus rhythm and restrictive LV diastolic filling, as indicated by
a short DT irrespective of the filling pattern. Patients under-
went a second Doppler echocardiographic study after 6 months
of optimized oral therapy following well established therapeu-
tic protocols. Although medical treatment was unblinded,
Doppler DT results at the late evaluation did not influence
subsequent selection of therapy, and no specific therapeutic
regimen was independently related to survival.
In the present study we excluded patients with atrial
fibrillation. However, in light of the recent evidence of similar
hemodynamic correlations of early mitral DT in patients either
in sinus rhythm or with atrial fibrillation (25), we can speculate
that our results are reliably applicable also to patients with
atrial fibrillation. Further studies are warranted in this subset
of patients.
Conclusions. The increase of an initially short DT of early
filling obtained with long-term optimal oral therapy predicts a
more favorable prognosis in clinically stable patients with CHF
due to LV systolic dysfunction. Our results indicate that in
these patients, serial evaluations of Doppler transmitral flow
may be useful in monitoring the progression of the disease and
the effects of long-term medical treatment. We believe that the
reversibility of restrictive LV diastolic filling in response to
optimized therapy, as evidenced by the prolongation of a short
DT by mitral Doppler echocardiography, easy to obtain and
reliable, should be included in the noninvasive prognostication
of all patients with CHF.
Table 5. Multivariate Cox Proportional Hazards Models
Variable Chi-Square p Value RR (95% CI)
Ranked Independent Predictors of Cardiovascular Mortality
Prolonged vs. persistent
short DT
15.7 0.000 0.34 (2.20 to 0.09)
Mod–severe TR 8.78 0.003 1.37 (1.31 to 1.95)
DLVEF 7.02 0.008 0.87 (1.09 to 0.82)
LVESVI at entry 4.47 0.034 1.00 (1.00 to 1.02)
Ranked Independent Predictors of Hospital Admission for Worsening HF
Prolonged vs. persistent
short DT
27.13 0.000 0.15 (2.92 to 20.86)
Mod–severe TR 4.49 0.034 1.57 (1.57 to 2.49)
Ranked Independent Predictors of Cumulative Hard Events (death, transplantation and hospital admission for
worsening HF)
Prolonged vs. persistent
short DT
38.39 0.000 0.22 (2.39 to 20.62)
DLVEF 12.78 0.000 0.83 (1.10 to 0.75)
Mod–severe TR 8.95 0.003 1.38 (1.26 to 1.92)
NYHA class 4.73 0.030 1.55 (1.48 to 2.37)
CI 5 confidence interval; RR 5 relative risk; other abbreviations as in Tables 1, 3 and 4.
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Figure 1. Cumulative survival rates for cardiac mortality as an event
(A); cumulative survival rates free of hospital admission for CHF (B);
and cumulative survival rates free of all cardiac events (death, trans-
plantation and hospital admission for worsening heart failure) in the
two study groups according to the value of DT of early filling:
prolonged DT (.125 ms) versus persistent short DT (#125 ms).
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